Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Kayvon Modjarrad, Nelson L. Michael, Andrew J. Hale et al.|The Lancet|2017

Cited by 196